Status | Study |
Not yet recruiting |
Study Name: An Observational Study on Epithelioid Sarcoma Condition: Epithelioid Sarcoma Date: 2017-03-17 Interventions: Other: Treatment for Epitheloid Sarcoma Treatment Epitheloid Sarcoma according the disease guideline |
Recruiting |
Study Name: Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Condition: Metastatic Angiosarcoma Metastatic Epithelioid Sarcoma Date: 2016-12-05 Interventions: Drug: Doxorubicin Given IV |
Recruiting |
Study Name: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Condition: Malignant Rhabdoid Tumors (MRT) Rhabdoid Tumors of the Kidney (RTK) Date: 2015-10-21 Interventions: Drug: Tazemetostat Tazemetostat (EPZ-6438) is a selective small molecule inhibitor of the histone-lysine |
Recruiting |
Study Name: Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma, Soft Tissue Soft Tissue Sarcoma Undifferentiated Date: 2015-10-12 Interventions: Drug: Dexrazoxane Other Names: |
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition: Adult Fibrosarcoma Alveolar Soft Part Sarcoma Angiomatoid Date: 2014-07-01 Interventions: Drug: Doxorubicin Hydrochloride |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-06-06 Interventions: Biological: cixutumumab Given |
Completed |
Study Name: Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-03-27 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Terminated |
Study Name: Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma Date: 2010-08-25 Interventions: Drug: doxorubicin hydrochloride Drug: trab |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |